OmniChart

XCH sharegardener 05 Oct 2015

Apollo offers 170 Capita offered 145 then 160 as a 'final' offer, Apollo have now offered 170. Capita may come back with a higher bid but on of basis of a bird in the hand etc I have sold out at 166. I didnt check earlier or may have got 170 but Im still up about 30% overall.As the price is hovering below 170 and XCH have opened to due diligence to Apollo then this bid may well go through.SG

APR arborman 05 Oct 2015

RNS In discussions about a takeoverHappy days

ENEG merce dismal 05 Oct 2015

Do Yourselves A Favour Get back into FTSE shares...you will get capital and dividend growth. Great time to buy into both BP & Lloy.AIM has had its day and the global recession and even depression to come (imminently, imho) will make this a market that literally disappears thro' lack of interest and risk aversion, owing to companies like this which are constant non-deliverers.Play safe with what you have left and sell all your stock in this and other similar ventures PDQ, before you go down completely with them.Anyone who believes this little lot are going to survive, never mind recover, needs an appointment at the "funny farm".MD (Mac Donald)

MIRA spike501 05 Oct 2015

Re: Update Down to 6p to sell now - this is either a massive overreaction for what is nothing but a delay of revenues for around 6 months or a placing is coming that is going to add significant dilution. I would suggest its likely any placing would be made at 5p given the current share price and a at least a million would raised so dilution of 20-25%.I'd be extremely annoyed from the lack of planning and it would further damage sentiment but it still would it still wouldn't fundamentally change the attractiveness once licence revenues start flowing from Televisa.

BLV paddington_bear 05 Oct 2015

Off my radar now Sold out, fortunately before the latest acquisition. The only point in holding this share was the dividend yield, but since July two acquisitions funded by placings to dilute share base, because of insufficient accumulated and retained profits. Was 24million shares costing 6.8p per share at uncovered 5.6 EPS, or £1,633,000. Since July 3.24m placed at 125p and now 3.1m placed at 116p, meaning an extra 6.34m shares or approx 26% more. Where will money come from to pay necessary £425,000 just to maintain existing level of dviidend as both deals are stated to be earnings beneficial from next year. Further drag on performance, apart from the bank debt, is over £4million in soft loans made to some franchisees. I cannot support this management further.PB

LEG BOWOOD 05 Oct 2015

VS Value VS now has a valuation put on it of more than £4m or 0.20p per LEG share. Add in the other investee company and the odds and ends and we have a valuation of 0.25p + and the VS stake growing in value following the recent investment by an impressive investor

GRG ignateus ignoramus 05 Oct 2015

Optimistic for tomorrow I am feeling optimistic for tomorrow.The LFL's in the most recent period,, that they are anouncing tomorrow will not be as good as the first six months but then they are set against much tougher comparatives.I think perversely that the general market sell-off has done Greggs a favour, and the news tomorrow, which will be a LFL increase of 4.5%in the most recent period I believe, will allow for an increase in the share price.This was always going to be the anouncement that no one dared to predict, because the second half of last year was so good, but I have bitten the bullet.The strong buy is for the long term as ever.

RRL jl 05 Oct 2015

So after promising to leave that bell-end called Wehatespammers on the lse board has gone nowhere. Probably got lonely in his sad life without compny of other trolls brikcet and Saltdome

AKR gretel 05 Oct 2015

Billion dollar opportunity [link] on 1 Oct 2015Raymond Akers, chief executive of Akers Biosciences (LON:AKR), reckons the global heparin-induced thrombocytopenia (HIT) test industry is not far away from being valued as a US$1bn market.Akers is a front runner in the space and has distribution for its own HIT test in every major diagnostic market after inking agreements for India, Germany, Italy and Scandinavia.Millions of patients are exposed to heparin around the world each year and between 1% and 5% of those patients receive a HIT diagnosis.The test is the only US and EU cleared rapid test to detect a potentially fatal allergy to the widely used blood thinner, heparin.That allergy reverses the effect of heparin and turns it into a clotting agent, which is clearly very dangerous."

ABF Rhigos 05 Oct 2015

Re: New all time high Reached new high again today, currently over £34. Decided time to take some profits so sold 20% of my ABF shares at a shade under £34 when limit order met at market opening. I felt I was overweight in these shares which are still my largest share holding by value at 7.0% thanks to the way they keep going up. Liberium Capital broker have a buy recommendation with a target of £34.50 which seems quite plausible in a month or two.I will consider buying again if SP falls to around £28.50.

MXP pannon 05 Oct 2015

Re: R.I.P. MXP So ca I know write these off in tax retain for CGT purposes? Is this possible as shares can't be traded?

ENRT Thomas Tallis 05 Oct 2015

Re: 13 Million traded last Friday? Correction - "other sites do not show more than 2 mill."

ENRT Thomas Tallis 05 Oct 2015

13 Million traded last Friday? Yahoo finance shows 13,138,907 traded on 2nd October but other sites do not show more than 1 mill.Assuming that this is not erroneous information from Yahoo, I would like to think that we will hear of a director buyng, but after the news last week, I expect it to be more a case of someone dumping their holdingI still expect the sp to drop below 0.1p, to perhaps 0.05p - but I will be very pleased to be proven wrong.

TNI wuffet 05 Oct 2015

Re: back in Hiyasorry I meant £200m for local world not £180m (I was assuming net cash £20m at year end which is where the confusion came in). All other numbers are the same.

TNI wuffet 05 Oct 2015

back in HiyaIts been a while but I got back in over the last couple of months when the shares fell sharply and the upside reached 100% - in my humble opinion. They are now on a slow unsteady recovery tack, The cash-flow remains as strong as ever which is a key driver - although the pension payment rises to £36m next year from circa £20m this year.I'm assuming at some point it will get to 6x ev/ebit which is a share price of 240p. even if you assume they buy out local world (they own I think 21% already) they will maybe shell out £180m for say £30m of ebit and this will only knock 8p off that share price target but give them further efficiency gains longer term which is important in printing.this is a risky proposition but as risk and return are correlated it's all part of the game. good luck